Research Article
RSC Medicinal Chemistry
9 K. M. Boy, J. M. Guernon, D. S. Zuev, L. Xu, Y. Zhang, J. Shi,
L. R. Marcin, M. A. Higgins, Y.-J. Wu, S. Krishnananthan, J.
Li, A. Trehan, D. Smith, J. H. Toyn, J. E. Meredith, C. R.
Burton, S. R. Kimura, T. Zvyaga, X. Zhuo, K. A. Lentz, J. E.
Grace, R. Denton, J. S. Morrison, A. Mathur, C. F. Albright,
M. K. Ahlijanian, R. E. Olson, L. A. Thompson and J. E.
Macor, Identification and Preclinical Evaluation of the
Bicyclic Pyrimidine γ-Secretase Modulator BMS-932481, ACS
Med. Chem. Lett., 2019, 10(3), 312–317.
10 J. E. Ahn, C. Carrieri, F. Dela Cruz, T. Fullerton, E. Hajos-
Korcsok, P. He, C. Kantaridis, C. Leurent, R. Liu, J. Mancuso,
L. Mendes da Costa and R. Qiu, Pharmacokinetic and
Pharmacodynamic Effects of a γ-Secretase Modulator, PF-
06648671, on CSF Amyloid-β Peptides in Randomized Phase
I Studies, Clin. Pharmacol. Ther., 2020, 107(1), 211–220.
11 K. Baumann, E. Goetschi, L. Green, S. Jolidon, H. Knust, A.
Limberg, T. Luebbers and A. Thomas, Preparation of
20 P. K. Mykhailiuk, Saturated bioisosteres of benzene: where
to go next?, Org. Biomol. Chem., 2019, 17(11), 2839–2849.
21 T. C. Fessard, K. Goncharenko, Q. Lefebvre and C. Salome,
Pushing the frontiers of accessible chemical space to
unleash design creativity and accelerate drug discovery,
Chimia, 2020, 74(10), 803–807.
22 A. F. Stepan, C. Subramanyam, I. V. Efremov, J. K. Dutra,
T. J. O'Sullivan, K. J. DiRico, W. S. McDonald, A. Won, P. H.
Dorff, C. E. Nolan, S. L. Becker, L. R. Pustilnik, D. R. Riddell,
G. W. Kauffman, B. L. Kormos, L. Zhang, Y. Lu, S. H.
Capetta, M. E. Green, K. Karki, E. Sibley, K. P. Atchison, A. J.
Hallgren, C. E. Oborski, A. E. Robshaw, B. Sneed and C. J.
O'Donnell, Application of the Bicyclo[1.1.1]pentane Motif as
a Nonclassical Phenyl Ring Bioisostere in the Design of a
Potent and Orally Active γ-Secretase Inhibitor, J. Med. Chem.,
2012, 55(7), 3414–3424.
23 N. D. Measom, K. D. Down, D. J. Hirst, C. Jamieson,
E. S. Manas, V. K. Patel and D. O. Somers, Investigation
of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within
an LpPLA2 Inhibitor, ACS Med. Chem. Lett., 2017, 8(1),
43–48.
24 Y. L. Goh, Y. T. Cui, V. Pendharkar and V. A. Adsool, Toward
Resolving the Resveratrol Conundrum: Synthesis and in Vivo
Pharmacokinetic Evaluation of BCP-Resveratrol, ACS Med.
Chem. Lett., 2017, 8(5), 516–520.
phenyltriazolopyridinylimidazolylphenylamine
derivatives
and analogs for use as gamma secretase modulators,
EP511842011092272, 20110128, 2011.
12 K. Baumann, L. Green, A. Limberg, T. Luebbers and A. Thomas,
Preparation of bridged piperidine derivatives for use as amyloid
beta modulators, EP533012012116965, 20120228, 2012.
13 R. M. Rodriguez Sarmiento, C. Bissantz, J. Bylund, A.
Limberg, W. Neidhart, R. Jakob-Roetne, L. Wang and K.
Baumann, Stepwise Design of γ-Secretase Modulators with
an Advanced Profile by Judicious Coordinated Structural
Replacements and an Unconventional Phenyl Ring
Bioisostere, J. Med. Chem., 2020, 63(15), 8534–8553.
14 H. Ratni, A. Alker, B. Bartels, C. Bissantz, W. Chen, I.
Gerlach, A. Limberg, M. Lu, W. Neidhart, S. Pichereau, M.
Reutlinger, R.-M. Rodriguez-Sarmiento, R. Jakob-Roetne, G.
Schmitt, E. Zhang and K. Baumann, Discovery of
RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as
a Potential Treatment for Alzheimer's Disease, ACS Med.
Chem. Lett., 2020, 11(6), 1257–1268.
25 Q. Pu, H. Zhang, L. Guo, M. Cheng, A. C. Doty, H. Ferguson,
X. Fradera, C. A. Lesburg, M. A. McGowan, J. R. Miller, P.
Geda, X. Song, K. Otte, N. Sciammetta, N. Solban, W. Yu,
D. L. Sloman, H. Zhou, A. Lammens, L. Neumann, D. J.
Bennett, A. Pasternak and Y. Han, Discovery of Potent and
Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-
2,3-dioxygenase 1 (IDO1) Inhibitors, ACS Med. Chem. Lett.,
2020, 11(8), 1548–1554.
26 X. Ma and L. Nhat Pham, Selected Topics in the Syntheses of
Bicyclo[1.1.1]pentane (BCP) Analogues. Asian, J. Org. Chem.,
2020, 9(1), 8–22.
15 A. Denisenko, P. Garbuz, S. V. Shishkina, N. M. Voloshchuk
and P. K. Mykhailiuk, Saturated Bioisosteres of ortho-
Substituted Benzenes, Angew. Chem., Int. Ed., 2020, 59(46),
20515–20521.
16 F. Lovering, J. Bikker and C. Humblet, Escape from Flatland:
Increasing Saturation as an Approach to Improving Clinical
Success, J. Med. Chem., 2009, 52(21), 6752–6756.
17 Y. P. Auberson, C. Brocklehurst, M. Furegati, T. C. Fessard,
G. Koch, A. Decker, L. La Vecchia and E. Briard, Improving
Nonspecific Binding and Solubility: Bicycloalkyl Groups and
Cubanes as para-Phenyl Bioisosteres, ChemMedChem,
2017, 12(8), 590–598.
27 J. Nugent, C. Arroniz, B. R. Shire, A. J. Sterling, H. D.
Pickford, M. L. J. Wong, S. J. Mansfield, D. F. J. Caputo, B.
Owen, J. J. Mousseau, F. Duarte and E. A. Anderson, A
General Route to Bicyclo[1.1.1]pentanes through Photoredox
Catalysis, ACS Catal., 2019, 9(10), 9568–9574.
28 D. F. J. Caputo, C. Arroniz, A. B. Durr, J. J. Mousseau,
A. F. Stepan, S. J. Mansfield and E. A. Anderson, Synthesis
and applications of highly functionalized 1-halo-3-
substituted bicyclo[1.1.1]pentanes, Chem. Sci., 2018, 9(23),
5295–5300.
29 J. Nugent, B. R. Shire, D. F. J. Caputo, H. D. Pickford, F.
Nightingale, I. T. T. Houlsby, J. J. Mousseau and E. A.
18 A. P. Hill and R. J. Young, Getting physical in drug discovery:
Anderson,
Synthesis
of
All-Carbon
Disubstituted
a
contemporary
perspective
on
solubility
and
Bicyclo[1.1.1]pentanes by Iron-Catalyzed Kumada Cross-
Coupling, Angew. Chem., Int. Ed., 2020, 59(29), 11866–11870.
30 R. M. Bychek, V. Hutskalova, Y. P. Bas, O. A. Zaporozhets, S.
Zozulya, V. V. Levterov and P. K. Mykhailiuk, Difluoro-
Substituted Bicyclo[1.1.1]pentanes for Medicinal Chemistry:
Design, Synthesis, and Characterization, J. Org. Chem.,
2019, 84(23), 15106–15117.
hydrophobicity, Drug Discovery Today, 2010, 15(15/16),
648–655.
19 M. R. Bauer, P. Di Fruscia, S. C. C. Lucas, I. N. Michaelides,
J. E. Nelson, R. I. Storer and B. C. Whitehurst, Put a ring on it:
application of small aliphatic rings in medicinal chemistry,
RSC Med. Chem., 2021, DOI: 10.1039/D0MD00370K.
RSC Med. Chem.
This journal is © The Royal Society of Chemistry 2021